Back

Understanding the role of RIPK1 kinase activity in atherogenesis: a genetic versus pharmacological approach

30 April 2022 (16:20 - 17:00)
Organised by: Logo
Congress Presentation Part of: Moderated poster 12 - Vascular Diseases Atherosclerosis, Cerebrovascular Diseases, Aneurysm, Restenosis CBS PREMIUM ACCESS Frontiers in CardioVascular Biomedicine 2022 Council on Basic Cardiovascular Science

About the speaker

Photo
Ms Pauline Puylaert

University of Antwerp, Antwerp (Belgium)

4 More presentations in this session

Presentation thumbnail
Targeting BACE1 to restore functional angiogenesis in type 2 diabetes
Miss E. Clavane (Leeds, GB)
Abstract
Presentation thumbnail
Smooth muscle cell-specific deletion of S100A4 reroutes smooth muscle cell fate and modifies the inflammatory status of murine atherosclerotic lesions
Mr L. Cardoso dos Santos (Stockholm, SE)
Abstract
Presentation thumbnail
Focused ultrasound-induced targeted delivery of miR-155-5p inhibitor employing biomimetic microbubbles reduces NADPH oxidase expression and inflammation in atherosclerotic ApoE-/- mice
Doctor A. Manea (Bucharest, RO)
Abstract
Presentation thumbnail
Necroptosis, unlike pyroptosis mediates right ventricular damage in pulmonary arterial hypertension
Miss I. Jarabicova (Bratislava, SK)
Abstract

Access the full session

Session thumbnail
Moderated poster 12 - Vascular Diseases

The Event

Event poster

Frontiers in CardioVascular Biomedicine 2022

30 April 2022 16:20 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources